Evidence map›Paper›PMID 31461215›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2019

The Crystallinity and Aspect Ratio of Cellulose Nanomaterials Determine Their Pro-Inflammatory and Immune Adjuvant Effects In Vitro and In Vivo.

Xiang Wang, Chong Hyun Chang, Jinhong Jiang, Qi Liu, Yu-Pei Liao, Jianqin Lu, Linjiang Li, Xiangsheng Liu, Joshua Kim, Ayman Ahmed and 2 more

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Polymer-Based Nanosystems-A Versatile Delivery Approach.Materials (Basel, Switzerland) · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiang WangDivision of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.ORCID 0000-0002-6647-0684
Chong Hyun ChangCalifornia NanoSystems Institute, University of California, Los Angeles, CA, 90095, USA.
Jinhong JiangCalifornia NanoSystems Institute, University of California, Los Angeles, CA, 90095, USA.
Qi LiuDivision of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.
Yu-Pei LiaoDivision of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.
Jianqin LuDivision of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.
Linjiang LiCalifornia NanoSystems Institute, University of California, Los Angeles, CA, 90095, USA.
Xiangsheng LiuDivision of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.
Joshua KimDepartment of Ecology and Evolutionary Biology, University of California, Los Angeles, CA, 90095, USA.
Ayman AhmedDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA, 90095, USA.
André E NelDivision of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.
Tian XiaDivision of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Engineered Nanomaterial Synthesis, Characterization and Method Development Center for Nano-safety ResearchU24ES026946 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI DEMOKRITOU, PHILIP · 2016 to 2020
$3.8M
Toxicological Profiling of Engineered Nanomaterials (ENMs) in the MPS (RES)U01ES027237 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEL, ANDRE ELIAS, XIA, TIAN · 2016 to 2020
$2.2M
NIDDK NIH HHS P30 DK041301NIEHS NIH HHS U01 ES027237NIEHS NIH HHS U24 ES026946
6 · The paper itself

Abstract

Nanocellulose is increasingly considered for applications; however, the fibrillar nature, crystalline phase, and surface reactivity of these high aspect ratio nanomaterials need to be considered for safe biomedical use. Here a comprehensive analysis of the impact of cellulose nanofibrils (CNF) and nanocrystals (CNC) is performed using materials provided by the Nanomaterial Health Implications Research Consortium of the National Institute of Environmental Health Sciences. An intermediary length of nanocrystals is also derived by acid hydrolysis. While all CNFs and CNCs are devoid of cytotoxicity, 210 and 280 nm fluorescein isothiocyanate (FITC)-labeled CNCs show higher cellular uptake than longer and shorter CNCs or CNFs. Moreover, CNCs in the 200-300 nm length scale are more likely to induce lysosomal damage, NLRP3 inflammasome activation, and IL-1β production than CNFs. The pro-inflammatory effects of CNCs are correlated with higher crystallinity index, surface hydroxyl density, and reactive oxygen species generation. In addition, CNFs and CNCs can induce maturation of bone marrow-derived dendritic cells and CNCs (and to a lesser extent CNFs) are found to exert adjuvant effects in ovalbumin (OVA)-injected mice, particularly for 210 and 280 nm CNCs. All considered, the data demonstrate the importance of length scale, crystallinity, and surface reactivity in shaping the innate immune response to nanocellulose.

Indexed as

Adjuvants, ImmunologicAnimalsCell SurvivalCelluloseCrystallizationDendritic CellsGlutathioneHumansHydrodynamicsImmunity, HumoralImmunoglobulin GInflammasomesInflammationInterleukin-1betaLysosomesMice, Inbred C57BLAdjuvants, ImmunologicCelluloseGlutathioneImmunoglobulin GInflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseOvalbuminReactive Oxygen Speciesaspect ratiocellulose nanocrystalscellulose nanofibrilscrystallinityhumoral immune effects

Identifiers

PMID31461215
PMCPMC6800804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.